A Comparison of Open Reduction and Internal Fixation and Primary Total Elbow Arthroplasty in the Treatment of Intraarticular Distal Humerus Fractures in Women Older Than Age 65

J Orthop Trauma · 2003 · Classic · cited 376 times

Mark A. Frankle, Dolfi Herscovici, Thomas DiPasquale, Matthew Vasey, Roy Sanders

Orthopaedic Trauma Shoulder & Elbow Hand & Upper Extremity

SUMMARY — THE REDUCTIONIn women over 65 with intraarticular distal humerus fractures, total elbow arthroplasty produced better Mayo Elbow scores and no revisions versus ORIF, supporting TEA especially in patients with comorbidities like osteoporosis or rheumatoid arthritis.
Abstract, as published

OBJECTIVE: To compare open reduction and internal fixation (ORIF) with total elbow arthroplasty (TEA) for intraarticular distal humerus fractures in women older than 65 years of age. DESIGN: Retrospective review. SETTING: Information was obtained from a Level 1 trauma center with fellowship-trained traumatologists and a tertiary care center with fellowship-trained shoulder and elbow surgeons. PATIENTS: Patients were 24 women older than age 65 who sustained distal humerus fractures that required surgical treatment with clinical follow-up at a minimum of 2 years. All fractures were OTA classification 13.C2 or 13.C3. No patients were lost to follow-up. INTERVENTION: ORIF or TEA was the treatment method. MAIN OUTCOME MEASUREMENTS: The Mayo Elbow Performance score and the need for revision surgery were established as the means of patient evaluation. RESULTS AND CONCLUSIONS: Using the Mayo Elbow Performance score, the outcomes of the 12 patients treated with ORIF were as follows: 4 excellent, 4 good, 1 fair, and 3 poor (cases that required conversion to TEA). Outcomes of the 12 patients treated with TEA were as follows: 11 excellent and 1 good. There were no fair or poor outcomes in the TEA group. No patients treated with TEA required revision surgery. We believe TEA to be a viable treatment option for distal intraarticular humerus fractures in women older than age 65. This is particularly true for women with associated comorbidities, such as rheumatoid arthritis, osteoporosis, and conditions requiring the use of systemic steroids.

Featured in the 2026-09-24 issue.

← Ability of Deep Learning to Predict Surgical Recommendations …The Effects of Diabetes and Diabetic Medications on Bone Health. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.